Dr. Niklas Beschorner is Chief Technology Officer (CTO) and co-founder of PROVIREX. He is responsible for ATMP manufacturing and R&D, driving the development of enabling technologies, translational processes, and novel delivery approaches for recombinase-based therapies. He brings deep scientific and operational expertise in HIV cure research and the advancement of innovative antiviral treatment strategies.